Steve Feldman, MD, PhD, of Wake Forest University School of Medicine, discusses various effective treatments for alleviating itch in patients with atopic dermatitis (AD), including dupilumab and Janus ...
Casey Butrus, PharmD: Dr Cameron, what’s the typical onset of action when you’re looking at a topical therapy vs a systemic therapy? Which 1 provides quicker relief for your patients? Michael Cameron, ...
The itch won’t quit. So you scratch. Then your skin burns, cracks, and flares. If you have atopic dermatitis (AD), you know the cycle all too well. Maybe you’ve tried steroid creams or other ointments ...
Validation study data show AdvanceAD-Tx can identify patients with AD who have a ‘JAKi responder profile’ and a superior ...
Please provide your email address to receive an email when new articles are posted on . Ruxolitinib-treated patients achieved greater differences from baseline in itch intensity vs. vehicle. More ...
Interleukins are a driver of atopic dermatitis, fueling inflammation and itch. Managing itch requires a mix of moisturizers, lifestyle changes and target therapies such as IL inhibitors. In this ...
Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...
Arcutis Biotherapeutics, Inc., a commercial-stage biopharmaceutical company focused on developing innovations in immuno-dermatology, announced the U.S. Food and Drug Administration has approved the ...
A small study recently found that the experimental drug nemolizumab (Mitchga) substantially improved itching in people with atopic dermatitis (AD). These improvements, in turn, were associated with ...
From relentless itching and painful flare-ups to sleepless nights and emotional exhaustion, eczema can take a serious toll on ...
Akeso, Inc. (($HK:9926)) announced an update on their ongoing clinical study. Akeso, Inc. is conducting a clinical study titled ‘A Multicenter, ...
Atopic dermatitis, the most common type of eczema, is a chronic inflammatory skin disease that can affect anyone. But research shows that it’s more prevalent in certain communities of color, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback